Protective Effects of Gemigliptin, a Dipeptidyl Peptidase-4 Inhibitor, against Cisplatin-Induced Nephrotoxicity in Mice

Dipeptidyl peptidase-4 (DPP-4) inhibitors are widely used antihyperglycemic agents for the treatment of type 2 diabetes mellitus. Recently, the pleiotropic actions of DPP-4 inhibitors have drawn much attention. In the present study, we aimed to examine whether gemigliptin, a recently developed DPP-4...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Seung Hee, Leem, Jaechan, Lee, In-Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727799/
https://www.ncbi.nlm.nih.gov/pubmed/29317794
http://dx.doi.org/10.1155/2017/4139439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727799/
https://www.ncbi.nlm.nih.gov/pubmed/29317794
http://dx.doi.org/10.1155/2017/4139439

Ejemplares similares